Drug-Induced Oxidative Stress and Toxicity

被引:450
作者
Deavall, Damian G. [1 ]
Martin, Elizabeth A. [1 ]
Horner, Judith M. [1 ]
Roberts, Ruth [1 ]
机构
[1] AstraZeneca, Safety Assessment, Alderley Pk, Macclesfield SK10 4TG, Cheshire, England
关键词
D O I
10.1155/2012/645460
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Reactive oxygen species (ROS) are a byproduct of normal metabolism and have roles in cell signaling and homeostasis. Species include oxygen radicals and reactive nonradicals. Mechanisms exist that regulate cellular levels of ROS, as their reactive naturemay otherwise cause damage to key cellular components including DNA, protein, and lipid. When the cellular antioxidant capacity is exceeded, oxidative stress can result. Pleiotropic deleterious effects of oxidative stress are observed in numerous disease states and are also implicated in a variety of drug-induced toxicities. In this paper, we examine the nature of ROS-induced damage on key cellular targets of oxidative stress. We also review evidence implicating ROS in clinically relevant, drug-related side effects including doxorubicin-induced cardiac damage, azidothymidine- induced myopathy, and cisplatin-induced ototoxicity.
引用
收藏
页数:13
相关论文
共 117 条
  • [1] Role of p53 in sensing oxidative DNA damage in response to reactive oxygen species-generating agents
    Achanta, G
    Huang, P
    [J]. CANCER RESEARCH, 2004, 64 (17) : 6233 - 6239
  • [2] Pro-oxidant Properties of AZT and other Thymidine Analogues in Macrophages: Implication of the Azido Moiety in Oxidative Stress
    Amatore, Christian
    Arbault, Stephane
    Jaouen, Gerard
    Koh, Alaric C. W.
    Leong, Weng Kee
    Top, Siden
    Valleron, Marie-Alice
    Woo, Chang Hong
    [J]. CHEMMEDCHEM, 2010, 5 (02) : 296 - 301
  • [3] Molecular targets of oxidative stress
    Avery, Simon V.
    [J]. BIOCHEMICAL JOURNAL, 2011, 434 : 201 - 210
  • [4] BANDYOPADHYAY S, 1994, J BIOL CHEM, V269, P29949
  • [5] Cellular and mitochondrial toxicity of zidovudine (AZT), didanosine (ddI) and zalcitabine (ddC) on cultured human muscle cells
    Benbrik, E
    Chariot, P
    Bonavaud, S
    AmmiSaid, M
    Frisdal, E
    Rey, C
    Gherardi, R
    BarlovatzMeimon, G
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1997, 149 (01) : 19 - 25
  • [6] Savior and slayer: the two faces of p53
    Bensaad, K
    Vousden, KH
    [J]. NATURE MEDICINE, 2005, 11 (12) : 1278 - 1279
  • [7] Protein oxidation in aging, disease, and oxidative stress
    Berlett, BS
    Stadtman, ER
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (33) : 20313 - 20316
  • [8] Diclofenac-induced liver injury: a paradigm of idiosyncratic drug toxicity
    Boelsterli, UA
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 2003, 192 (03) : 307 - 322
  • [9] Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer
    Bokemeyer, C
    Berger, CC
    Hartmann, JT
    Kollmannsberger, C
    Schmoll, HJ
    Kuczyk, MA
    Kanz, L
    [J]. BRITISH JOURNAL OF CANCER, 1998, 77 (08) : 1355 - 1362
  • [10] Influence of pharmacogenetics on response and toxicity in breast cancer patients treated with doxorubicin and cyclophosphamide
    Bray, J.
    Sludden, J.
    Griffin, M. J.
    Cole, M.
    Verrill, M.
    Jamieson, D.
    Boddy, A. V.
    [J]. BRITISH JOURNAL OF CANCER, 2010, 102 (06) : 1003 - 1009